Annual Total Assets
$5.42 M
-$17.33 M-76.18%
31 December 2023
Summary:
Seelos Therapeutics annual total assets is currently $5.42 million, with the most recent change of -$17.33 million (-76.18%) on 31 December 2023. During the last 3 years, it has fallen by -$12.08 million (-69.03%). SEEL annual total assets is now -93.51% below its all-time high of $83.50 million, reached on 31 December 2021.SEEL Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$2.38 M
-$1.23 M-34.08%
30 June 2024
Summary:
Seelos Therapeutics quarterly total assets is currently $2.38 million, with the most recent change of -$1.23 million (-34.08%) on 30 June 2024. Over the past year, it has dropped by -$3.84 million (-61.71%). SEEL quarterly total assets is now -97.36% below its all-time high of $90.31 million, reached on 30 June 2021.SEEL Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.2% | -61.7% |
| 3 y3 years | -69.0% | -97.1% |
| 5 y5 years | +44.1% | -85.3% |
SEEL Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -93.5% | at low | -97.2% | at low |
| 5 y | 5 years | -93.5% | +44.1% | -97.4% | at low |
| alltime | all time | -93.5% | +132.2% | -97.4% | at low |
Seelos Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $2.38 M(-34.1%) |
| Mar 2024 | - | $3.61 M(-33.3%) |
| Dec 2023 | $5.42 M(-76.2%) | $5.42 M(-12.9%) |
| Sept 2023 | - | $6.22 M(-47.7%) |
| June 2023 | - | $11.89 M(-49.7%) |
| Mar 2023 | - | $23.64 M(+3.9%) |
| Dec 2022 | $22.75 M(-72.8%) | $22.75 M(-43.8%) |
| Sept 2022 | - | $40.51 M(-23.1%) |
| June 2022 | - | $52.67 M(-25.5%) |
| Mar 2022 | - | $70.69 M(-15.3%) |
| Dec 2021 | $83.50 M(+377.3%) | $83.50 M(+3.2%) |
| Sept 2021 | - | $80.95 M(-10.4%) |
| June 2021 | - | $90.31 M(+118.3%) |
| Mar 2021 | - | $41.37 M(+136.5%) |
| Dec 2020 | $17.49 M(+57.7%) | $17.49 M(+77.1%) |
| Sept 2020 | - | $9.88 M(+27.3%) |
| June 2020 | - | $7.76 M(-45.2%) |
| Mar 2020 | - | $14.17 M(+27.7%) |
| Dec 2019 | $11.10 M(+195.1%) | $11.10 M(-31.6%) |
| Sept 2019 | - | $16.21 M(+57.7%) |
| June 2019 | - | $10.28 M(-16.7%) |
| Mar 2019 | - | $12.34 M(+228.3%) |
| Dec 2018 | $3.76 M(-43.9%) | $3.76 M(-32.4%) |
| Sept 2018 | - | $5.56 M(-23.0%) |
| June 2018 | - | $7.22 M(+20.0%) |
| Mar 2018 | - | $6.02 M(-10.2%) |
| Dec 2017 | $6.71 M(+42.7%) | $6.71 M(-24.0%) |
| Sept 2017 | - | $8.82 M(+0.1%) |
| June 2017 | - | $8.81 M(+64.7%) |
| Mar 2017 | - | $5.35 M(+13.9%) |
| Dec 2016 | $4.70 M(-39.6%) | $4.70 M(-44.1%) |
| Sept 2016 | - | $8.41 M(+36.4%) |
| June 2016 | - | $6.17 M(-40.9%) |
| Mar 2016 | - | $10.43 M(+34.1%) |
| Dec 2015 | $7.78 M(-47.5%) | $7.78 M(-18.9%) |
| Sept 2015 | - | $9.60 M(-15.7%) |
| June 2015 | - | $11.39 M(-42.0%) |
| Mar 2015 | - | $19.64 M(+32.6%) |
| Dec 2014 | $14.81 M(-36.5%) | $14.81 M(-25.2%) |
| Sept 2014 | - | $19.80 M(-2.4%) |
| June 2014 | - | $20.29 M(-18.8%) |
| Mar 2014 | - | $24.99 M(+7.2%) |
| Dec 2013 | $23.31 M(-2.4%) | $23.31 M(+4.5%) |
| Sept 2013 | - | $22.30 M(-17.2%) |
| June 2013 | - | $26.92 M(+61.9%) |
| Mar 2013 | - | $16.63 M(-30.4%) |
| Dec 2012 | $23.88 M(+43.7%) | $23.88 M(-41.4%) |
| Sept 2012 | - | $40.75 M(+39.6%) |
| June 2012 | - | $29.20 M(-8.4%) |
| Mar 2012 | - | $31.88 M(+91.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $16.62 M(-11.9%) | $16.62 M(+18.9%) |
| Sept 2011 | - | $13.98 M(-0.7%) |
| June 2011 | - | $14.08 M(-28.2%) |
| Mar 2011 | - | $19.60 M(+3.9%) |
| Dec 2010 | $18.86 M(-9.9%) | $18.86 M(-12.8%) |
| Sept 2010 | - | $21.63 M(-11.6%) |
| June 2010 | - | $24.48 M(+9.8%) |
| Mar 2010 | - | $22.29 M(+6.5%) |
| Dec 2009 | $20.93 M(+144.6%) | $20.93 M(+214.9%) |
| Sept 2009 | - | $6.65 M(-17.4%) |
| June 2009 | - | $8.05 M(-12.6%) |
| Mar 2009 | - | $9.21 M(+7.7%) |
| Dec 2008 | $8.56 M(-19.8%) | $8.56 M(+2.5%) |
| Sept 2008 | - | $8.35 M(-20.5%) |
| June 2008 | - | $10.50 M(+11.4%) |
| Mar 2008 | - | $9.43 M(-11.7%) |
| Dec 2007 | $10.67 M(-46.5%) | $10.67 M(-4.6%) |
| Sept 2007 | - | $11.19 M(-14.4%) |
| June 2007 | - | $13.07 M(-28.2%) |
| Mar 2007 | - | $18.19 M(-8.7%) |
| Dec 2006 | $19.93 M(+49.5%) | $19.93 M(+40.3%) |
| Sept 2006 | - | $14.21 M(-11.6%) |
| June 2006 | - | $16.08 M(-8.2%) |
| Mar 2006 | - | $17.52 M(+31.4%) |
| Dec 2005 | $13.33 M(-34.2%) | $13.33 M(-22.8%) |
| Sept 2005 | - | $17.27 M(+12.5%) |
| June 2005 | - | $15.34 M(-0.1%) |
| Mar 2005 | - | $15.35 M(-24.3%) |
| Dec 2004 | $20.27 M(-12.4%) | $20.27 M(+13.8%) |
| Sept 2004 | - | $17.81 M(-22.7%) |
| June 2004 | - | $23.03 M(+19.9%) |
| Mar 2004 | - | $19.20 M(-17.0%) |
| Dec 2003 | $23.13 M(+63.6%) | $23.13 M(+14.3%) |
| Sept 2003 | - | $20.24 M(+48.5%) |
| June 2003 | - | $13.63 M(+10.6%) |
| Mar 2003 | - | $12.33 M(-12.8%) |
| Dec 2002 | $14.14 M(-48.2%) | $14.14 M(-23.3%) |
| Sept 2002 | - | $18.42 M(-26.5%) |
| June 2002 | - | $25.06 M(+18.2%) |
| Mar 2002 | - | $21.21 M(-22.4%) |
| Dec 2001 | $27.31 M(-31.7%) | $27.31 M(-14.4%) |
| Sept 2001 | - | $31.91 M(-6.4%) |
| June 2001 | - | $34.11 M(-9.5%) |
| Mar 2001 | - | $37.67 M(-5.8%) |
| Dec 2000 | $39.99 M(+426.2%) | $39.99 M(-4.7%) |
| Sept 2000 | - | $41.97 M(+123.7%) |
| June 2000 | - | $18.76 M(+52.2%) |
| Mar 2000 | - | $12.32 M |
| Dec 1999 | $7.60 M(+28.3%) | - |
| Dec 1998 | $5.92 M(+154.0%) | - |
| Dec 1997 | $2.33 M | - |
FAQ
- What is Seelos Therapeutics annual total assets?
- What is the all time high annual total assets for Seelos Therapeutics?
- What is Seelos Therapeutics annual total assets year-on-year change?
- What is Seelos Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly total assets year-on-year change?
What is Seelos Therapeutics annual total assets?
The current annual total assets of SEEL is $5.42 M
What is the all time high annual total assets for Seelos Therapeutics?
Seelos Therapeutics all-time high annual total assets is $83.50 M
What is Seelos Therapeutics annual total assets year-on-year change?
Over the past year, SEEL annual total assets has changed by -$17.33 M (-76.18%)
What is Seelos Therapeutics quarterly total assets?
The current quarterly total assets of SEEL is $2.38 M
What is the all time high quarterly total assets for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly total assets is $90.31 M
What is Seelos Therapeutics quarterly total assets year-on-year change?
Over the past year, SEEL quarterly total assets has changed by -$3.84 M (-61.71%)